Edith Shahbol

Title: The Innovative Contributions of Edith Shahbol

Introduction

Edith Shahbol is a notable inventor based in Northridge, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the detection of antidepressants. Her work has implications for both clinical and research settings, enhancing the understanding of serotonin and norepinephrine reuptake inhibitors.

Latest Patents

Edith holds a patent for a method titled "Determination of antidepressants by mass spectrometry." This innovative technique involves detecting or determining the amount of one or more serotonin and norepinephrine reuptake inhibitors (SNRIs) and their metabolites in a sample using tandem mass spectrometry. The process includes subjecting the sample to ionization to produce detectable ions, determining the amount of these ions, and subsequently calculating the amount of SNRIs and their metabolites based on the ion data. Notably, this method includes the detection of duloxetine, a commonly used SNRI.

Career Highlights

Edith Shahbol is currently employed at Quest Diagnostics Investments, Inc., where she applies her expertise in mass spectrometry to advance pharmaceutical research. Her innovative approach to detecting antidepressants has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Edith has collaborated with talented professionals, including Anita Dermartirosian and Karin O Thomassian. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Edith Shahbol's contributions to the field of antidepressant detection through mass spectrometry exemplify her dedication to innovation in pharmaceuticals. Her work not only enhances the understanding of SNRIs but also paves the way for future advancements in the field.